Change in Director / Key Managerial Personnel

Nature of change: Re-appointment of two directors

Mr. Ram Mohan Lokhande (DIN 08117035):

  • Re-appointed as Whole Time Director
  • Effective from February 08, 2027 till February 07, 2032
  • Term: Five consecutive years
  • Current tenure expires on February 07, 2027
  • Brief profile: Seasoned pharmaceutical professional with extensive experience in Active Pharmaceutical Ingredients (API) manufacturing, project management, greenfield and brownfield projects commissioning, technology absorption, and plant operations
  • Qualifications: B. Tech - Chemical Engineering from National Institute of Technology, Warangal, Telangana
  • Expertise: Strategic planning, cost and budgetary controls, risk mitigation plans, sustainability initiatives, production planning and inventory control, project management, and quality systems
  • Not related to any other Directors or KMP of the Company
  • Not debarred from holding office of Director by virtue of any SEBI Order or any other authority

Mrs. Anita Bandyopadhyay (DIN 08672071):

  • Re-appointed as Non-Executive & Independent Director
  • Effective from February 08, 2027 till February 07, 2032
  • Term: Five consecutive years (second term)
  • Current tenure expires on February 07, 2027
  • Brief profile: Doctorate in Applied Psychology & Executive MBA from SP Jain Institute of Management & Research, Mumbai
  • Founder Director of Kafe HR and distinguished Human Resources professional
  • Expertise: Strategic human resource management, leadership development, talent management, performance management, organizational design, corporate succession planning, building organizational capability, and aligning people strategies with business objectives
  • Not related to any other Directors or KMP of the Company
  • Not debarred from holding office of Director by virtue of any SEBI Order or any other authority

Approval Details:

  • Approved by shareholders at 19th Annual General Meeting held on Thursday, September 24, 2026
  • Approval includes payment of remuneration for both directors
  • Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Reference to SEBI Master Circular bearing Ref. No. SEBI/HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026

Company Information:

  • NSE Symbol: ACUTAAS
  • Date of Disclosure: September 26, 2026
  • Compliance Officer: CS Ekta Kumari Srivastava, Company Secretary & Compliance Officer